165 related articles for article (PubMed ID: 19267712)
1. Adherence in patients transferred from immediate release metformin to a sustained release formulation: a population-based study.
Donnelly LA; Morris AD; Pearson ER
Diabetes Obes Metab; 2009 Apr; 11(4):338-42. PubMed ID: 19267712
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Adherence to Glimepiride/Metformin Sustained Release Once-daily Versus Glimepiride/Metformin Immediate Release BID Fixed-combination Therapy Using the Medication Event Monitoring System in Patients With Type 2 Diabetes.
Kim JD; Park CY; Cha BY; Ahn KJ; Kim IJ; Park KS; Lee HW; Min KW; Won JC; Chung MY; Kim JT; Kang JG; Park SW
Clin Ther; 2018 May; 40(5):752-761.e2. PubMed ID: 29729957
[TBL] [Abstract][Full Text] [Related]
3. Glycemic control in patients with type 2 diabetes mellitus switched from twice-daily immediate-release metformin to a once-daily extended-release formulation.
Fujioka K; Pans M; Joyal S
Clin Ther; 2003 Feb; 25(2):515-29. PubMed ID: 12749511
[TBL] [Abstract][Full Text] [Related]
4. Effects of metformin extended release compared to immediate release formula on glycemic control and glycemic variability in patients with type 2 diabetes.
Derosa G; D'Angelo A; Romano D; Maffioli P
Drug Des Devel Ther; 2017; 11():1481-1488. PubMed ID: 28553078
[TBL] [Abstract][Full Text] [Related]
5. Efficacy, dose-response relationship and safety of once-daily extended-release metformin (Glucophage XR) in type 2 diabetic patients with inadequate glycaemic control despite prior treatment with diet and exercise: results from two double-blind, placebo-controlled studies.
Fujioka K; Brazg RL; Raz I; Bruce S; Joyal S; Swanink R; Pans M
Diabetes Obes Metab; 2005 Jan; 7(1):28-39. PubMed ID: 15642073
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of glimepiride/metformin sustained release once daily vs. glimepiride/metformin twice daily in patients with type 2 diabetes.
Hwang YC; Kang M; Ahn CW; Park JS; Baik SH; Chung DJ; Jang HC; Kim KA; Lee IK; Min KW; Nam M; Park TS; Son SM; Sung YA; Woo JT; Park KS; Lee MK
Int J Clin Pract; 2013 Mar; 67(3):236-43. PubMed ID: 23336668
[TBL] [Abstract][Full Text] [Related]
7. Metformin extended-release versus immediate-release: An international, randomized, double-blind, head-to-head trial in pharmacotherapy-naïve patients with type 2 diabetes.
Aggarwal N; Singla A; Mathieu C; Montanya E; Pfeiffer AFH; Johnsson E; Zhao J; Iqbal N; Bailey C
Diabetes Obes Metab; 2018 Feb; 20(2):463-467. PubMed ID: 28857388
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Clinical Efficacy and Safety of Metformin Sustained-Release Tablet (II) (Dulening) and Metformin Tablet (Glucophage) in Treatment of Type 2 Diabetes Mellitus.
Guo LX; Liu GE; Chen L; Wang HF; Guo J; Zheng XL; Duan BH; Wang DZ; Zhu W; Wang K; Tan WS; Chen Q; Li QZ; Yang J; Zhang Q; Xie PF; Lei MX
Front Endocrinol (Lausanne); 2021; 12():712200. PubMed ID: 34659110
[TBL] [Abstract][Full Text] [Related]
9. Dose Comparison And Side Effect Profile Of Metformin Extended Release Versus Metformin Immediate Release.
Hameed M; Khan K; Salman S; Mehmood N
J Ayub Med Coll Abbottabad; 2017; 29(2):225-229. PubMed ID: 28718236
[TBL] [Abstract][Full Text] [Related]
10. Improved glycemic control with minimal systemic metformin exposure: Effects of Metformin Delayed-Release (Metformin DR) targeting the lower bowel over 16 weeks in a randomized trial in subjects with type 2 diabetes.
Henry RR; Frias JP; Walsh B; Skare S; Hemming J; Burns C; Bicsak TA; Baron A; Fineman M
PLoS One; 2018; 13(9):e0203946. PubMed ID: 30252913
[TBL] [Abstract][Full Text] [Related]
11. Hypoglycaemic symptoms, treatment satisfaction, adherence and their associations with glycaemic goal in patients with type 2 diabetes mellitus: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) Study.
Alvarez Guisasola F; Tofé Povedano S; Krishnarajah G; Lyu R; Mavros P; Yin D
Diabetes Obes Metab; 2008 Jun; 10 Suppl 1():25-32. PubMed ID: 18435671
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of empagliflozin twice daily versus once daily in patients with type 2 diabetes inadequately controlled on metformin: a 16-week, randomized, placebo-controlled trial.
Ross S; Thamer C; Cescutti J; Meinicke T; Woerle HJ; Broedl UC
Diabetes Obes Metab; 2015 Jul; 17(7):699-702. PubMed ID: 25827441
[TBL] [Abstract][Full Text] [Related]
13. Adherence to prescribed oral hypoglycaemic medication in a population of patients with Type 2 diabetes: a retrospective cohort study.
Donnan PT; MacDonald TM; Morris AD
Diabet Med; 2002 Apr; 19(4):279-84. PubMed ID: 11942998
[TBL] [Abstract][Full Text] [Related]
14. Initial therapy with the fixed-dose combination of sitagliptin and metformin results in greater improvement in glycaemic control compared with pioglitazone monotherapy in patients with type 2 diabetes.
Wainstein J; Katz L; Engel SS; Xu L; Golm GT; Hussain S; O'Neill EA; Kaufman KD; Goldstein BJ
Diabetes Obes Metab; 2012 May; 14(5):409-18. PubMed ID: 22059736
[TBL] [Abstract][Full Text] [Related]
15. Adding saxagliptin to extended-release metformin vs. uptitrating metformin dosage.
Fonseca V; Zhu T; Karyekar C; Hirshberg B
Diabetes Obes Metab; 2012 Apr; 14(4):365-71. PubMed ID: 22192246
[TBL] [Abstract][Full Text] [Related]
16. Extended-release metformin hydrochloride. Single-composition osmotic tablet formulation.
Wagstaff AJ; Figgitt DP
Treat Endocrinol; 2004; 3(5):327-32. PubMed ID: 15330682
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy and safety of extended-release metformin in treatment of type 2 diabetes mellitus].
Zhang JP; Yang WY; Hong TP; Yang JK; Xiao WH; Gao HW; Yang Y
Zhonghua Yi Xue Za Zhi; 2007 May; 87(18):1238-40. PubMed ID: 17686255
[TBL] [Abstract][Full Text] [Related]
18. Both slow-release and regular-form metformin improve glycemic control without altering plasma visfatin level in patients with type 2 diabetes mellitus.
Hsieh CH; He CT; Lee CH; Wu LY; Hung YJ
Metabolism; 2007 Aug; 56(8):1087-92. PubMed ID: 17618954
[TBL] [Abstract][Full Text] [Related]
19. Improved glycaemic control with vildagliptin added to insulin, with or without metformin, in patients with type 2 diabetes mellitus.
Kothny W; Foley J; Kozlovski P; Shao Q; Gallwitz B; Lukashevich V
Diabetes Obes Metab; 2013 Mar; 15(3):252-7. PubMed ID: 23039321
[TBL] [Abstract][Full Text] [Related]
20. Haemoglobin A1c goal attainment in relation to dose in patients with diabetes mellitus taking metformin: a nested, case-control study.
Penning-van Beest FJ; Wolffenbuttel BH; Herings RM
Clin Drug Investig; 2008; 28(8):487-93. PubMed ID: 18598094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
